Physician profile
Samip S Patel
NPI 1932302551
$10,083.29
in general payments reported to CMS, 2019-2025
68 companies · $2,427 in 2025
The $2,427 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2020: $423 · 2021: $711 · 2022: $779 · 2023: $1,840 · 2024: $2,038 · 2025: $2,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,304.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,108.81 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $746.36 | 2019-2025 | |
| Livanova USA, INC. | $695.93 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Pfizer INC. | $668.34 | 2023-2025 | |
| Biogen, INC. | $540.53 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Lilly USA, LLC | $537.11 | 2019-2025 | Emgality, Reyvow, Kisunla |
| Teva Pharmaceuticals USA, INC. | $496.44 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amgen INC. | $438.28 | 2019-2025 | Uplizna |
| Lundbeck LLC | $352.88 | 2019-2025 | Vyepti |
| Grifols USA, LLC | $229.53 | 2019-2025 | Gamunex-C |
| Eisai INC. | $226.07 | 2022-2025 | |
| Csl Behring | $216.38 | 2019-2025 | Hizentra |
| Genentech USA, INC. | $205.66 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Celgene Corporation | $203.54 | 2022-2025 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $182.11 | 2020-2025 | Hyqvia, Gammagard |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samip Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.